TVM Capital Healthcare’s Southeast Asia Fund Raises $150 Mn in First Closing

The TVM Healthcare Southeast Asia Fund will focus post-acute and rehabilitation services, women’s health, diabetic and oncology care, and local manufacturing of essential pharmaceuticals.

TVM Capital Healthcare, a global private equity investor specializing in healthcare growth across emerging markets, announced the first closing of its USD 150 million TVM Healthcare Southeast Asia Fund (SEA Fund).

The SEA Fund is the third generation of TVM Capital Healthcare’s investment funds and builds on nearly 40 years of global healthcare investment and operator experience, including more than 15 years of scaling healthcare companies across the Middle East and Southeast Asia.

The firm has a strong record of creating leading specialty care providers and advancing innovative care models outside traditional hospital settings to expand access and improve healthcare delivery.

Commitments to the SEA Fund have come from a broad group of institutional investors. A cornerstone investor is Invest International, founded by the Dutch government and FMO to support Dutch businesses and international partners with financing solutions that promote sustainable economic growth and create positive social and environmental impact worldwide.

The TVM Healthcare Southeast Asia Fund will focus on under-penetrated segments where demand is high but supply remains limited.

These include post-acute and rehabilitation services, women’s health, diabetic and oncology care, and local manufacturing of essential pharmaceuticals.

The fund aims to strengthen healthcare resilience as an investment sector and highlight its importance to economic and social development.

In addition to scaling local specialty care clinics into national and regional leaders, TVM Capital Healthcare also invests in healthcare innovators from the US and Europe. The firm supports their expansion into Southeast Asian markets and builds cross-border partnerships, such as those with Harvard-affiliated teaching hospitals and leading European medtech companies.

These collaborations aim to transfer proven healthcare models, advanced medical technologies, and global best practices into local healthcare ecosystems.

The firm’s investment model emphasizes operational partnerships, global accreditations, and robust governance structures. This enables healthcare companies to grow into best-in-class businesses and supports the leapfrogging of emerging healthcare systems to new standards of care.

Stay tuned for more such updates on Digital Health News